2010 Volume 74 Issue 11 Pages 2333-2335
The effects of soybean-derived phospholipid, PIPS NAGASETM (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.
This article cannot obtain the latest cited-by information.